Exciting insights from our recent trip to the 3rd Annual Process Development for Cell Therapies Summit in Boston! Operations Manager Marnie Wilson and Process Development Lead Janna Kozuska came away with three key takeaways: 1) Collaboration between research teams and process development teams is crucial for bridging gaps and enhancing project outcomes. 2) Effective communication between the client and CDMO is essential for project success. 3) The summit highlighted that observing inherent particles during visual inspections in cell therapy is a common occurrence. Bonus takeaway: Trader Joe's Rules!!! #CDMO #celltherapies #processdevelopment #techtransfer #traderjoes
Alberta Cell Therapy Manufacturing (ACTM)’s Post
More Relevant Posts
-
ARPA-H has introduced the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic (ET), representing a crucial initiative designed to revolutionize the production and validation of autologous cell therapies. https://hubs.ly/Q02PSGvx0
-
-
ARPA-H has introduced the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic (ET), representing a crucial initiative designed to revolutionize the production and validation of autologous cell therapies. https://hubs.ly/Q02PSLb90
-
-
ARPA-H has introduced the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic (ET), representing a crucial initiative designed to revolutionize the production and validation of autologous cell therapies. https://hubs.ly/Q02PSCZH0
-
-
ARPA-H has introduced the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic (ET), representing a crucial initiative designed to revolutionize the production and validation of autologous cell therapies. https://hubs.ly/Q02PSNZ50
-
-
ARPA-H has introduced the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic (ET), representing a crucial initiative designed to revolutionize the production and validation of autologous cell therapies. https://hubs.ly/Q02PSCW10
-
-
Dive into the dynamic world of cell therapy with the release of the first part of our 2023 Landscape Review Series! Uncover the latest trends, challenges, and innovations that shaped the drug landscape. Download your copy now! https://ter.li/rzt2xj #CellTherapy #LandscapeReview
-
-
Director at EverGlade Consulting | Connecting public sector needs with private sector solutions
ARPA-H has introduced the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic (ET), representing a crucial initiative designed to revolutionize the production and validation of autologous cell therapies. https://hubs.ly/Q02PSNGs0
-
-
ARPA-H has introduced the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic (ET), representing a crucial initiative designed to revolutionize the production and validation of autologous cell therapies. https://hubs.ly/Q02MxfDB0
-
-
ARPA-H has introduced the Decentralized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic (ET), representing a crucial initiative designed to revolutionize the production and validation of autologous cell therapies. https://hubs.ly/Q02PSGtG0
-
-
Deadline tomorrow 🚨 Share your groundbreaking findings on HCT & cell therapy toxicities with global experts at #ToxicitiesConference24. Topics include solid organ malignancies, machine learning, novel approaches to improve outcomes, among others. Learn more & submit by Sept. 8: https://ow.ly/KCFr50T735J
-